Literature DB >> 5442010

Exercise tests in assessing children with lung or heart disease.

S Godfrey.   

Abstract

Entities:  

Mesh：

Year:  1970        PMID： 5442010      PMCID： PMC472174          DOI： 10.1136/thx.25.2.258

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  5 in total

1.  Evidence of microvascular dysfunction in patients with cystic fibrosis.

Authors:  Paula Rodriguez-Miguelez; Jeffrey Thomas; Nichole Seigler; Reva Crandall; Kathleen T McKie; Caralee Forseen; Ryan A Harris
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-04-15       Impact factor: 4.733

2.  A partially supervised physical activity program for adult and adolescent survivors of childhood cancer (SURfit): study design of a randomized controlled trial [NCT02730767].

Authors:  Corina S Rueegg; Susi Kriemler; Simeon J Zuercher; Christina Schindera; Andrea Renner; Helge Hebestreit; Christian Meier; Prisca Eser; Nicolas X von der Weid
Journal:  BMC Cancer       Date:  2017-12-05       Impact factor: 4.430

3.  Effects of a partially supervised conditioning programme in cystic fibrosis: an international multi-centre randomised controlled trial (ACTIVATE-CF): study protocol.

Authors:  Helge Hebestreit; Larry C Lands; Nancy Alarie; Jonathan Schaeff; Chantal Karila; David M Orenstein; Don S Urquhart; Erik H J Hulzebos; Lothar Stein; Christian Schindler; Susi Kriemler; Thomas Radtke
Journal:  BMC Pulm Med       Date:  2018-02-08       Impact factor: 3.317

4.  Exercise Capacity in Asymptomatic Adult Patients Treated for Coarctation of the Aorta.

Authors:  Elles J Dijkema; Gertjan Tj Sieswerda; Johannes M P J Breur; Felix Haas; Martijn G Slieker; Tim Takken
Journal:  Pediatr Cardiol       Date:  2019-08-07       Impact factor: 1.655

5.  Exercise responses in children and adults with a Fontan circulation at simulated altitude.

Authors:  Tim Takken; Alyanne Evertse; Fleur de Waard; Mandy Spoorenburg; Martijn Kuijpers; Christian Schroer; Erik H Hulzebos
Journal:  Congenit Heart Dis       Date:  2019-10-11       Impact factor: 2.007
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.